Dr. Jennifer Lockman is the Chief Executive Officer for Centerstone’s Research Institute.
Lockman joined Centerstone in 2007 and has extensive grant experience, having served as the principal investigator of two Garrett Lee Smith Suicide Prevention Grants and two National Strategies for Suicide Prevention grants (funded by SAMHSA). She earned her PhD in counseling psychology from Purdue University and her MS in professional counseling from Lipscomb University. She has published in professional journals and speaks regularly at national conferences focusing on suicide prevention and translational science.
Ashley Newton, MPS, PMP is Chief Operating Officer for Centerstone’s Research Institute and Vice President of the Center for Clinical Excellence.
Ashley joined Centerstone in 2006 and has held both clinical and leadership roles. In 2017, she was named Vice President of the Center for Clinical Excellence.
In her current role, Ashley continues to work closely with strategic business units to implement high value treatment in the context of the local environments.
Newton holds a BA in psychology and an MA in professional studies and strategic leadership from Middle Tennessee State University. She is a certified ACRA-ACC clinical supervisor and a Project Management Professional (PMP), the highest certification for project management.
Richard Shelton is the Chief Science Officer.
He attended medical school at the University of Louisville in Kentucky. He became a resident and Chief Resident at the Massachusetts Mental Health Center (now the Longwood Program), a teaching hospital of the Harvard Medical School. After residency, he was a research fellow at the National Institutes of Mental Health Intramural Program in Washington, D.C. before entering the faculty of Vanderbilt University in 1985. There, he became the James G. Blakemore Research Professor and Vice Chair for Clinical Research in the Department of Psychiatry. He also became a professor in the Departments of Psychology and Pharmacology.
Richard joined the Department of Psychiatry and Behavioral Neurobiology at the University of Alabama at Birmingham in February of 2012 as the Charles Byron Ireland Professor, Vice Chair for Research, and head of the Mood Disorders Research Program. He has served on NIH study sections and was the chair of the Adult Psychopathology and Disorders of Aging review group. He has also actively served as a teacher and mentor.
He has won the Excellence in Teaching Award from the residents of the Vanderbilt Department of Psychiatry four times and the residents of UAB Department of Psychiatry twice. He was recognized by the National Alliance for the Mentally Ill for his service to persons with serious and persistent mental illnesses with the Exemplary Psychiatrist Award in 1994 and 2012. He also received the Dorothea Dix Professional Service Award from the Tennessee Association of Mental Health Centers in 2007 in recognition of his impact on the practice of Psychiatry in the State of Tennessee.
Richard’s research focuses on the development of new treatments for depression and bipolar disorder (experimental therapeutics), including the identification of new targets for treatment, prevention of serious mental illnesses, testing novel therapies and identifying biomarkers of both disease and treatment response.
- Research Institute Board Members Back to top
- David J. Melby, PhD, Chair
- Jonathan Morphett, Vice-Chair
- Bob Williams, PhD, Secretary
- Janet Ayers, Immediate Past Chair
- Jennifer Lockman, PhD, CEO
- Jennifer Bencie
- Mark Faulkner
- Douglas J. Leonard
- Nedda Pollack
- A. John Rose
- Dr. Raghu Upender
View all Centerstone Board Members